Abstract
A common strategy in drug discovery is to identify small molecules that interact with a specific target receptor and then to perform iterations of structural optimisation to produce high-affinity lead compounds to progress into pre-clinical development. The last decade has witnessed the development of several sensitive, high-throughput NMR that have helped to rejuvenate NMR as a valuable tool for screening and characterising receptor-ligand interactions in the early stages of the drug discovery process. This chapter highlights the recent advances in NMR methods and technology that are now being implemented widely in pharmaceutical research for probing receptor-ligand interactions, and describes some of the emerging techniques that promise to be of value in the future. The NMR methods reviewed fall conveniently into two broad categories, namely, methods that detect the ligands and methods that observe the receptor target. Most of these methods can be implemented on conventional liquid-state spectrometers, but this chapter also draws attention to some recent examples of how solid-state NMR methods are providing information about ligand interactions with insoluble protein targets such as membrane-embedded receptors. It is also shown how NMR methods for characterising drug-membrane interactions are also proving useful in the structural optimisation of pharmaceutical lead compounds, as drug lipophilicity has implications for absorption, distribution and metabolism. The range of methods and their applications covered in this review, although not exhaustive, provide testament to the versatility of NMR, an advantage that will help to secure its future as an important and evolving technique in drug discovery.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.